cyc 202 has been researched along with hydroxyurea in 8 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (hydroxyurea) | Trials (hydroxyurea) | Recent Studies (post-2010) (hydroxyurea) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 8,969 | 741 | 2,156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Hayashi, K; Matsumoto, Y; Nishida, E | 1 |
| Cowan, RG; Harman, RM; Quirk, SM | 1 |
| Fernando, R; Foster, JS; Henley, D; Isbill, M; Wimalasena, J | 1 |
| Komina, O; Maurer, M; Wesierska-Gadek, J | 1 |
| Blow, JJ; Ge, XQ | 1 |
8 other study(ies) available for cyc 202 and hydroxyurea
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells.
Topics: 4-Butyrolactone; Animals; CDC2-CDC28 Kinases; Cell Cycle; Centrosome; CHO Cells; Cricetinae; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; G1 Phase; Gene Expression; Hydroxyurea; Mimosine; Protein Serine-Threonine Kinases; Purines; Roscovitine; S Phase | 1999 |
The susceptibility of granulosa cells to apoptosis is influenced by oestradiol and the cell cycle.
Topics: Animals; Apoptosis; Biomarkers; Bromodeoxyuridine; Cattle; Cell Proliferation; Cells, Cultured; Cyclins; Estradiol; Estrogen Antagonists; Fas Ligand Protein; Female; Flow Cytometry; Fulvestrant; G1 Phase; Granulosa Cells; Hydroxyurea; Immunohistochemistry; Interphase; Ki-67 Antigen; Membrane Glycoproteins; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Purines; Random Allocation; Roscovitine; S Phase; Tumor Necrosis Factors | 2006 |
Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Breast Neoplasms; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Fragmentation; Estradiol; Flow Cytometry; Fulvestrant; Humans; Hydroxyurea; Inhibitor of Apoptosis Proteins; JNK Mitogen-Activated Protein Kinases; Microtubule-Associated Proteins; Microtubules; Neoplasm Proteins; Paclitaxel; Purines; RNA, Small Interfering; Roscovitine; Spindle Apparatus; Survivin; Thymidine; Transfection | 2007 |
Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Division; Cell Proliferation; Cell Survival; Culture Media, Serum-Free; Cyclin-Dependent Kinases; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Flow Cytometry; G2 Phase; Humans; Hydroxyurea; Protein Kinase Inhibitors; Purines; Roscovitine; S Phase | 2009 |
Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories.
Topics: Aphidicolin; Ataxia Telangiectasia Mutated Proteins; Bromodeoxyuridine; Caffeine; Carbocyanines; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; Cyclin A; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Deoxyuracil Nucleotides; DNA; DNA Damage; DNA Replication; Fibroblasts; Gamma Rays; Humans; Hydroxyurea; Models, Biological; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Purines; Replication Origin; RNA, Small Interfering; Roscovitine | 2010 |